349 related articles for article (PubMed ID: 33975882)
1. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells.
Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA
Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882
[TBL] [Abstract][Full Text] [Related]
2. A Ca
Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
4. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
5. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
6. Phenotypically sorted highly and weakly migratory triple negative breast cancer cells exhibit migratory and metastatic commensalism.
Hapach LA; Wang W; Schwager SC; Pokhriyal D; Fabiano ED; Reinhart-King CA
Breast Cancer Res; 2023 Aug; 25(1):102. PubMed ID: 37649089
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
Klotz R; Thomas A; Teng T; Han SM; Iriondo O; Li L; Restrepo-Vassalli S; Wang A; Izadian N; MacKay M; Moon BS; Liu KJ; Ganesan SK; Lee G; Kang DS; Walmsley CS; Pinto C; Press MF; Lu W; Lu J; Juric D; Bardia A; Hicks J; Salhia B; Attenello F; Smith AD; Yu M
Cancer Discov; 2020 Jan; 10(1):86-103. PubMed ID: 31601552
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
9. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
10. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
[TBL] [Abstract][Full Text] [Related]
12. Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state.
Mizukoshi K; Okazawa Y; Haeno H; Koyama Y; Sulidan K; Komiyama H; Saeki H; Ohtsuji N; Ito Y; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
Int J Cancer; 2020 May; 146(9):2547-2562. PubMed ID: 31506938
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
Liu X; Tian X
Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
15. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
[TBL] [Abstract][Full Text] [Related]
16. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
18. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
[TBL] [Abstract][Full Text] [Related]
19. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin.
Lee J; Kim KE; Cheon S; Song JH; Houh Y; Kim TS; Gil M; Lee KJ; Kim S; Kim D; Hur DY; Yang Y; Bang SI; Park HJ; Cho D
Oncotarget; 2016 Oct; 7(40):65825-65836. PubMed ID: 27589563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
